Repligen (RGEN) Notes Payables (2017 - 2024)
Repligen (RGEN) has disclosed Notes Payables for 8 consecutive years, with $69.5 million as the latest value for Q2 2024.
- On a quarterly basis, Notes Payables fell 75.67% to $69.5 million in Q2 2024 year-over-year; TTM through Jun 2024 was $69.5 million, a 75.67% decrease, with the full-year FY2023 number at $69.5 million, down 75.6% from a year prior.
- Notes Payables was $69.5 million for Q2 2024 at Repligen, roughly flat from $69.5 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $286.0 million in Q3 2023 to a low of $69.5 million in Q4 2023.
- A 5-year average of $229.9 million and a median of $255.3 million in 2021 define the central range for Notes Payables.
- Peak YoY movement for Notes Payables: increased 14.89% in 2022, then crashed 75.67% in 2024.
- Repligen's Notes Payables stood at $243.7 million in 2020, then rose by 4.73% to $255.3 million in 2021, then grew by 11.5% to $284.6 million in 2022, then crashed by 75.6% to $69.5 million in 2023, then increased by 0.04% to $69.5 million in 2024.
- Per Business Quant, the three most recent readings for RGEN's Notes Payables are $69.5 million (Q2 2024), $69.5 million (Q1 2024), and $69.5 million (Q4 2023).